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Abstract
Background: There are no published studies on stem cells from equine cord blood although
commercial storage of equine cord blood for future autologous stem cell transplantations is
available. Mesenchymal stem cells (MSC) have been isolated from fresh umbilical cord blood of
humans collected non-invasively at the time of birth and from sheep cord blood collected invasively
by a surgical intrauterine approach. Mesenchymal stem cells isolation percentage from frozen-
thawed human cord blood is low and the future isolation percentage of MSCs from cryopreserved
equine cord blood is therefore expectedly low. The hypothesis of this study was that equine MSCs
could be isolated from fresh whole equine cord blood.
Results: Cord blood was collected from 7 foals immediately after foaling. The mononuclear cell
fraction was isolated by Ficoll density centrifugation and cultured in a DMEM low glucose based
media at 38.5°C in humidified atmosphere containing 5% CO2. In 4 out of 7 samples colonies with
MSC morphology were observed. Cellular morphology varied between monolayers of elongated
spindle-shaped cells to layered cell clusters of cuboidal cells with shorter cytoplasmic extensions.
Positive Alizarin Red and von Kossa staining as well as significant calcium deposition and alkaline
phosphatase activity confirmed osteogenesis. Histology and positive Safranin O staining of matrix
glycosaminoglycans illustrated chondrogenesis. Oil Red O staining of lipid droplets confirmed
adipogenesis.
Conclusion: We here report, for the first time, the isolation of mesenchymal-like stem cells from
fresh equine cord blood and their differentiation into osteocytes, chondrocytes and adipocytes.
This novel isolation of equine cord blood MSCs and their preliminary in vitro differentiation
positions the horse as the ideal pre-clinical animal model for proof-of-principle studies of cord
blood derived MSCs.
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In 2004, 115 thousand new Thoroughbred foals were reg-
istered worldwide [1] for whom orthopaedic injuries will
be the most common cause of lost training days or prema-
ture retirement [2-5]. Traumatic osteoarthritis (OA) is esti-
mated to constitute 60% of all equine lameness issues
making it the leading cause of equine lameness [6]. Oste-
ochondrosis (OC) lesions are other important causes of
joint disease in the horse [7,8].
Currently, there are no medical treatments available that
can reverse cartilage injuries and most are only palliative
in mild to moderate cases. Surgical cartilage and osteo-
chondral resurfacing techniques in horses with focal OA
or OC aims at either stimulated endogenous repair and or
grafting of tissues [6]. Currently the surgical technique of
choice for stimulated endogenous repair is abrasion
arthroplasty alone or combined with subchondral bone
microfracture [6]. The long-term clinical efficacy of this
approach has not been reported. Grafting of equine tis-
sues and cells for OA and OC repair remains experimental
due to technical and biological problems. Retaining the
transplant while maintaining articular surface congruity at
the recipient site is a significant problem and the harvest
of autologous graft material requires multiple surgeries or
multiple surgery sites with increased risk to the patient
[6,9]. Equine bone marrow derived autologous MSCs
require time consuming in vitro propagation prior to
transplantation and a decreased yield of stem cells from
the bone marrow with increasing age makes the technique
age-dependent which is paradoxical to the fact that many
clinical cases are aged individuals [10]. Genetic modifica-
tion of bone marrow derived equine MSCs might help to
overcome some of these problems [11].
Mesenchymal stem cells or unrestricted somatic stem cells
(USSCs) have been isolated from fresh umbilical cord
blood of humans collected non-invasively at the time of
birth [12,13] and from sheep cord blood collected inva-
sively by a surgical intrauterine approach [14]. Human
cord blood non-hematopoietic stem cells have been dif-
ferentiated into multiple cell types such as endothelial
cells, neurons, smooth muscle cells, adipocytes, chond-
roblasts and osteoblasts [12,13,15-23]. Cartilaginous tis-
sue has been produced in vitro from sheep cord blood
[14]. Comparative studies of human bone marrow, adi-
pose tissue and cord blood derived MSCs revealed differ-
ences in isolation frequency, proliferative capacity, in vitro
differentiation potential, telomere length, and telomerase
activity [12,13,16]. Human cord blood derived hemat-
opoietic stem cells might even be immunologically privi-
leged compared to bone marrow derived hematopoietic
stem cells [24].
In the horse, the isolation percentage of MSCs from
peripheral blood is very low and bone marrow is currently
the main source of equine MSCs [25-29]. There are no
peer-reviewed reports of equine adipose tissue derived
stem cells although commercial marketing of so-called
equine adipose tissue derived stem cell therapy is taken
place today [30]. There appears to be no published studies
on equine cord blood stem cells, hematopoietic or mesen-
chymal, although commercial storage of equine cord
blood for possible future autologous stem cell transplan-
tations is available [29]. Mesenchymal stem cells isolation
from thawed human cord blood is associated with signif-
icantly reduce success [31,32] and the future isolation per-
centage of MSCs from cryopreserved equine cord blood is
therefore expectedly low.
Isolation of MSCs cells from equine umbilical cord blood
could provide a non-invasive source of stem cells with
potentially superior cellular characteristic to other equine
stem cells with regard to immune tolerance, proliferative
potential and differentiation potency. This study reports
the isolation of cryopreservation and thawing tolerant
MSCs from fresh equine cord blood with in vitro differen-
tiation potential towards the osteogenic, chondrogenic
and adipogenic cell lineages.
Results
Cord blood collection
No complications were encountered upon umbilical cord
blood collection. The storage and transport temperature
was 15–22°C (mean 17.9°C), transport time was 8–24
hours (mean 15 hours), sample volume was 65–250 ml
(mean 168 ml ± 36.08 S.E. ml), and no sample had signs
of coagulation or hemolysis.
Isolation and propagation
In 4 out of 7 cord blood samples colonies with the classi-
cal MSCs morphology of adherent fibroblastoid spindle-
shaped cells growing in a monolayer were observed (Fig.
1a) giving an isolation percentage success rate of 4/7 (×
100 = 57%). The numbers of primary colonies from each
sample were 1, 5, 2 and 1, respectively. Colonies were
observed as early as 3 days post seeding and the first sub-
culture was done 7 days after initial seeding. One sample
containing putative MSCs colonies were subsequently dis-
carded due to fungal contamination. Although the over-
all appearance of passaged cells was that of spindle-
shaped cells, cellular morphology did vary between very
slender and elongated to more cuboidal cells with shorter
cytoplasmic extensions with a layered growth (Fig. 1b).
These morphological differences were seen within and
between cord blood samples. Undifferentiated cells have
been passaged up to 10 times and population-doubling
times were calculated for a subset of cell passages. ThePage 2 of 9
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per day with a mean of 0.77.
In vitro differentiation results
All the depicted results in figures and pictures of the in
vitro differentiation studies are from experiments per-
formed on cryopreserved and thawed cells. Similar results
were obtained from experiments performed with "fresh"
undifferentiated cells which had not been previously cry-
opreserved.
Osteogenic induced cell cultures changed morphology
from adherent monolayer of swirling spindle-shaped
cells, which was still apparent in the control cultures (Fig.
2a), to layered cell clusters surrounded by a matrix-like
substance positive upon Alizarin Red S (Fig. 2b) and von
Kossa staining (data not shown). Statistically significant
(p < 0.001) higher quantities of calcium deposition and
alkaline phosphatase activity at the 95% confidence level
were also demonstrated in these osteogenic induced cul-
ture wells (Fig. 3 & 4). The total protein content of the cul-
ture wells was significantly (p < 0.001) lower in the
osteogenic induced wells compared to the control wells
indicating a lower cellularity in the induced wells (Fig. 4).
Classical histological morphology of hyaline cartilage
after 2 and 4 weeks of culture was evident upon staining
of pellet sections with hematoxylin and eosin (Fig. 2c).
Safranin O staining revealed marked deposition of gly-
cosaminoglycans in the matrix (Fig. 2d). In comparison
with control cultures in regular expansion media (Fig. 2e),
marked adipogenic differentiation occurred in the pres-
ence of adipogenic induction media spiked with rabbit
serum (Fig. 2f).
Discussion
Equine umbilical cord blood was collected without com-
plications to the mare or foal at the time of foaling using
a standard commercially available blood transfusion bag
system. Mesenchymal stem cells with in vitro differentia-
tion potency towards the osteogenic, chondrogenic and
adipogenic cell fates were successfully isolated from the
cord blood. The undifferentiated MSCs have been cryop-
reserved, thawed and expanded post-thawing without
obvious loss of morphology, proliferative potential and
differentiation capacity.
The volume of blood collected was markedly higher
(mean 168 ml) than what has been reported in human
studies (mean 42.8 ml, range 13–80 ml [12]; mean 60.9
ml, range 17–141,5 ml [33]). The MSCs isolation fre-
quency of 57% is very similar to reported isolation fre-
quencies in human studies of up to 63% [12]. However,
these high isolation frequencies are often only obtained in
a subset of human cord blood samples after applying var-
ious critical parameters [12]. Correlating the number of
primary colonies to the volume of blood processed might
help determine whether this apparently high success rate
is due to the higher volume of equine blood collected or
due to higher inherent precursor frequency of these cells
in equine cord blood compared to human cord blood.
Here, the precursor frequency was very low with primary
colonies varying between 1 and 5 per sample, indicating
that this stem cell population is a very rare cell type, which
is in correlation with human studies [12,13]. The different
morphologies of undifferentiated cells are intriguing since
they might reflect inherently different stem cell pheno-
types. Morphological and differentiation potency differ-
ences between USSCs and "true" MSCs have been
Isolation of mesenchymal stem cells from equine umbilical cord bloodFigure 1
Isolation of mesenchymal stem cells from equine 
umbilical cord blood. (a) Monolayer of rapidly expanding 
adherent spindle-shaped fibroblastoid cells compatible with 
undifferentiated mesenchymal stem cells (× 100). (b) Three-
dimensional, relief contrast image of cell cluster of rapidly 
expanding adherent spindle-shaped fibroblastoid cells com-
patible with undifferentiated mesenchymal stem cell mor-
phology (× 100).Page 3 of 9
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Alizarin Red positive nodules after six to eight passages
and lack endodermic potential; whereas USSCs retain
spindle-shaped fibroblastoid cell morphology in monol-
ayer and have endodermic potential [13,32]. Whether the
different morphologies noted in this study reflect USSCs
and MSCs is undetermined, but warrants further investi-
gation. So-far reduced growth rates have not been
observed during sub-culturing. However, the number of
samples is insufficient to draw any conclusion regarding
the proliferative potential of these cells and how their pro-
liferative potential might compare to equine bone mar-
row, and possibly equine adipose-derived MSCs.
Although further molecular characterization is required,
the osteogenic and chondrogenic potency of these cells
has been convincingly demonstrated in this study. No
monoclonal antibodies are presently available for immu-
nophenotyping equine mesenchymal stem cells and a
specific panel of MSC markers has not been reported in
the scientific literature. If and when such an equine MSC
marker panel is available, screening and cell separation of
the undifferentiated umbilical cord blood derived MSCs
would be very interesting in order to compare the immu-
nophenotye profile of these cells with that of human cord
blood derived MSCs and that of equine bone marrow and
possibly adipose tissue derived MSCs. Nevertheless, oste-
ogenesis has been demonstrated by both morphological
and functional criteria as established in previous studies
of MSCs [12,13]. Chondrogenic assessment was used
using established methods and our histological findings
of typical hyaline cartilage morphology with gly-
cosaminoglycan containing matrix is in accordance with
other similar studies of MSCs [13,34]. Koerner and col-
leagues (2006) reported that adult equine peripheral
blood progenitor cells did not show any capacity to pro-
duce cartilage at the histological level [25]. This apparent
difference in chondrogenic differentiation potential
between equine cord blood and adult peripheral blood is
undetermined but warrants further investigation. Adipo-
genesis of peripheral blood derived MSCs from adult
horses was previously shown successfully, although
reduced adipogenic potential was noted compared to
human MSCs [25]. Here, rabbit serum was added to the
commercial adipogenic induction media based on the
work by Janderova and colleagues (2003) in which supe-
rior adipogenesis was demonstrated [35]. Adipogenic dif-
ferentiation of the equine cord blood derived MSCs were
only successful with the addition of rabbit serum to the
In vitro differentiation studiesFigure 2
In vitro differentiation studies. (a) Osteogenic control 
after 21 days in regular expansion media maintained normal 
morphology and stain negative for Alizarin Red S (× 100). (b) 
Osteogenic induction after 21 days shows marked morpho-
logical changes and extensive extra cellular calcium deposi-
tion as demonstrated by positive Alizarin red S staining (× 
100). (c) Haematoxylin and Eosin stain of chondrogenic 
induced micro pellet showing classical hyaline cartilage mor-
phology with lacunae containing chondrocytes surrounded 
by extra cellular matrix (× 100). (d) Safranin O staining of 
glycosaminoglycans in the cartilage matrix (× 100). (e) Adi-
pogenic control culture after exposure to regular expansion 
media shows maintenance of undifferentiated morphology 
and minor lipid droplet deposition (× 200). (f) Positive adipo-
genic induction after culture in adipogenic induction media 
spiked with 15% rabbit serum as demonstrated by morpho-
logical change towards larger cells with marked lipid droplet 
deposition stained with Oil Red O (× 200).
Alkaline phosphatase activity in control and induced osteo-genic differentiation s mplesFigure 3
Alkaline phosphatase activity in control and induced 
osteogenic differentiation samples. Significant statistical 
difference (*) at the 95% level between control and induced 
was found at 5, 10, 15 and 20 minutes with p-values of < 
0.001 at each time point. No difference was present at time 0 
(p = 0.1418).Page 4 of 9
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equine peripheral blood MSCs versus equine cord blood
MSCs cannot be made at this point in time, since the adi-
pogenic potential observed for both cell types was dem-
onstrated under different culture conditions. Whether
there is an inherent difference between these blood-
derived blood MSCs responsible for our failure to induce
adipogenesis without the addition of rabbit serum is
undetermined. Also, the effect of rabbit serum on the adi-
pogenic differentiation potential of adult equine blood
MSCs is unknown. Adipogenesis was unsuccessful for
human cord blood derived MSCs cultured in rabbit serum
deficient media [16]. Whether this is a methodological
difference or a cellular difference between equine and
human cord blood MSCs warrants further studies.
Equine cord blood MSCs might have superior cellular
characteristic to other equine stem cells with regard to
immune tolerance, proliferative potential and differentia-
tion potency, which are desirable traits in selection of cells
for tissue engineering. Comparative studies of human
bone marrow, adipose tissue and cord blood derived
MSCs revealed lower isolation frequency from cord blood
compared to bone marrow and adipose tissue, but cord
blood derived MSCs had higher proliferative potential
than both bone marrow and adipose tissue derived MSCs
[16]. Longer telomeres, higher telomerase activity and
superior in vitro proliferation capacity and differentiation
potential of human cord blood MSCs compared to
human bone marrow and adipose tissue derived MSCs
have also been reported [12,13]. Human leukemia
patients transfused with HLA mismatched cord blood
compared to transfusions of HLA matched bone marrow
showed no difference in treatment outcome [24] indicat-
ing that cord blood derived stem cells might be immuno-
logically privileged compared to bone marrow derived
stem cells. The exact immunogenic potential of umbilical
cord blood derived MSCs remain undetermined. Banking
of ELA matched cord blood derived stem cells would
therefore be the safest approach for allogenic-based tissue
engineering or stem cell-based therapies at the moment.
Isolation of MSCs from cryopreserved cord blood is very
difficult and MSCs isolation and expansion should be car-
ried out from fresh cord blood prior to long-term cryop-
reservation [31,32].
The impact of orthopaedic injuries to the health and reve-
nue of the individual racehorse can be dramatic as was
recently illustrated by the catastrophic and life-threaten-
ing injury that the 2006 Kentucky Derby champion "Bar-
baro" sustained during the 2006 Preakness Stakes. The
financial magnitude of Thoroughbred racing in general is
illustrated by the fact that in 2004 a total of 171 thousand
Thoroughbred races were completed worldwide compet-
ing for a total purse value of 4 billion US dollars [1]. Bear-
ing this in mind there is naturally a great interest in new
possible treatment modalities for equine orthopaedic
injuries which is also illustrated by the experimental
application of autologous bone marrow MSCs and adi-
pose tissue derived cell products to race and non-race
horses with especially tendon problems [28-30]. The
horse is a recognized animal model of OA induced inju-
ries at various orthopaedic research facilities around the
world for several reasons; the pathophysiology of OA
appears similar between horses and humans, there are sig-
nificant similarities in joint cartilage composition
between horse and man and the shear size of horse joints
and structures makes surgical manipulation easy com-
pared to other domestic animal models [36]. The horse
also provides a unique opportunity of studying naturally
occurring injuries, which in many cases have considerable
resemblance to injuries in human athletes. Deliveries of
racehorses are generally observed making large-scale cord
blood collection very feasible. For all of the above-men-
tioned similarities between horse and man, the horse now
appears as a very favourable pre-clinical animal model for
cord blood MSC research.
Conclusion
This novel discovery of MSCs cells in equine cord blood
and our preliminary insights into the differentiation
potential of these cells could have significant future
impact on the equine industry and individual horse
health, but could also to generate significant biological,
technical and procedural knowledge spillover and poten-
tially proof-of-principle for future therapeutic uses of
human cord blood derived USSCs or MSCs.
Methods
Cord blood collection
Cord blood was collected, without complications to the
mare or foal, from seven foals immediately after foaling.
Mean calcium and protein levels in osteogenic differentiation studies of cord blood mesenchymal m cellsFigure 4
Mean calcium and protein levels in osteogenic differ-
entiation studies of cord blood mesenchymal stem 
cells. Significant difference in calcium deposition between 
control and osteo-induced cultures was apparent (*, p < 
0.001). There were significantly elevated protein levels per 
culture well in controls compared to osteo-induced cultures 
(*, p < 0.001).Page 5 of 9
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Care Committee at the University of Guelph (AUP
06R076). Cord blood was collected immediately after
foaling and before the umbilical cord broke spontane-
ously or was broken according to farm management pro-
tocol. Venipuncture of the umbilical vein was performed
with a 16 G hypodermic needle attached to a 450 ml
blood transfusion collection bag (Fenwal) containing cit-
rate phosphate dextrose adenine as the anticoagulant
solution. The blood was then stored and transported at
ambient temperature to the laboratory as quickly as pos-
sible.
Mononuclear cell fraction isolation, seeding and MSC 
culture
The mononuclear cell fraction (MNCF) was isolated by
carefully loading 30 ml of whole blood onto 10 ml of
Ficoll density media (GE Healthcare Bio-Sciences) in 50
ml polypropylene tubes, centrifuge for 30 minutes at
room temperature at 450 × g and the interphase collected
after aspirating and discarding the supernatant. The inter-
phase was washed with 20 ml PBS and centrifuged at 150
× g for 5 minutes at room temperature. The supernatant
was aspirated and the cells were washed with PBS a second
time. The cells were re-suspended in the isolation media
and transferred to 6-well culture dishes that had been pre-
treated with 100% FBS (Invitrogen) for 30–60 minutes to
prevent adherence of monocytic cells as described by Bie-
back et al. (2004) [12]. The isolation media was low-glu-
cose DMEM (Cambrex Bio Science) supplemented with
30% FBS, low dexamethazone (10-7 M) (Sigma-Aldrich),
penicillin (100 IU/ml) (Invitrogen), streptomycin (0.1
mg/ml) (Invitrogen), and ultraglutamine (2 mM) (Cam-
brex Bio-Science) as described by Kögler et al. (2004) [13].
Incubation was at 38.5°C in humidified atmosphere con-
taining 5% CO2.
The isolation media was completely replaced after over-
night incubation (12–18 hours) in order to remove non-
adherent cells. Hereafter the media was completely
replaced every 3 days until putative MSC colonies were
noted. The cultures was inspected daily for formation of
adherent spindle-shaped fibroblastoid cell colonies con-
sistent with putative MSCs or contaminating osteo-like
nodules and fungi. Initially expansion was done in 6-well
culture dishes in order to allow pick-to-save procedures.
Sub-culturing was performed at 60–80% confluence,
when day-to-day colonic expansion was judged to slow
down, or if signs of cellular detachment from the dish
were noted in the center of the colony. Sub-culturing was
done by chemical detachment using 0.04% trypsin/
0.03%EDTA or by mechanically picking fibroblastoid col-
onies with a wiretrol pipette. Replating ratio after chemi-
cal cell detachment was 1:3. The cells in the second plate
were referred to as passage 1 cells (P1). Dexamethasone
was omitted from the expansion media, which was other-
wise identical to the isolation media. Later, when cell
numbers allowed, expansion was done in 25 cm2 or 75
cm2 tissue culture flasks. Cells were seeded at densities of
3000 – 25000 cells per cm2. Cells were cryopreserved after
various passages numbers.
Cryopreservation and thawing of MSCs
Cells were detached by 0.04% trypsin/0.03% EDTA (1 ml
per 6–8 cm2 culture surface area), washed in expansion
media at 3 times the volume of trypsin/EDTA, spun down
at 150 × g for 5 minutes, the supernatant was discarded
and expansion media was added until the cell concentra-
tion was 1,000,000 – 2,000,000 cells per ml, then 1 ml of
cold freezing solution, (DMEM high-glucose (Invitrogen)
containing 10% FBS and 20% DMSO (Sigma-Aldrich))
was added per 1 ml of cell suspension and aliquots of 2
ml was stored overnight (12–18 hours) at -80°C in a iso-
propanol freezing canister. The next day the vials were
plunged into liquid Nitrogen for long-term storage in liq-
uid nitrogen.
Cryovials were thawed in a 37°C water bath for less than
3 minutes. The cells were immediately transferred to 5 ml
of 37°C equilibrated expansion media and gently vor-
texed. The cells were centrifuged at 150 × g for 5 minutes
at room temperature. The cell pellet was resuspended in a
minimum volume of expansion media to allow a total cell
count. Further expansion media was then added pending
on the desired inoculum's cell concentration and volume.
In vitro differentiation studies
Osteogenic, chondrogenic and adipogenic differentiation
potential has been evaluated for one of the three propa-
gated cell lines isolated both before and after cryopreser-
vation.
Osteogenic differentiation
Undifferentiated cells were induced towards the osteo-
genic lineage using the protocol described by Jaiswal et al.
(1997) [37]. Putative MSCs was seeded in six-well plates
at a density of approximately 3000 cells/cm2 and cultured
in expansion media until reaching 90–100% confluence.
Osteogenic differentiation was hereafter induced by cul-
turing the cells for 20 days in osteogenic induction
medium consisting of 100 nM dexamethasone, 10 mM β-
glycerophosphate (Sigma-Aldrich), 0.05 mM L-ascorbic
acid-2-phosphate (Fluka Biochemika), and 10% FBS in
low glucose DMEM. As a negative control an equal
number of wells were maintained in expansion media for
20 days. The media in both groups were completely
replaced every 4 days. Osteogenesis was evaluated by
colorimetric semi-quantitative assessment of calcium dep-
osition and alkaline phosphatase activity as well as by Ali-
zarin Red S and von Kossa histological staining.Page 6 of 9
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Calcium deposition was evaluated according to the proto-
col described by Cambrex Bio Science [38]. All culture
media was aspirated from each well and the wells were
washed with 1 ml of PBS twice. After aspiration of the sec-
ond PBS wash 0.5 ml of 0.5N HCl was added to each well.
The cells were scraped of the well and transferred to a 1.5
ml Eppendorf tube. An additional 0.5 ml of 0.5NHCl was
added to each well in order to wash of any remaining cells
and this wash fluid was added to the Eppendorf tube.
Eppendorf tubes with fresh samples were placed on an
orbital shaker for 6 hours at 4°C. The Eppendorf tubes
were then centrifuged at 500 × g for 2 minutes. The super-
natant, containing the extracted calcium, was carefully
aspirated without disrupting the pellet and transferred to
another 1.5 ml Eppendorf tube. A standard curve was gen-
erated following the instruction provided in the Stanbio
Laboratory Calcium (CPC) Liquicolor® kit and the cal-
cium concentration in control and osteo-induced samples
were then determined. The calcium absorbance was meas-
ured at 570 nm by spectrometry.
Semi-quantitative alkaline phosphatase enzyme activity 
assay
Cell lysate supernatant was evaluated for alkaline phos-
phatase activity. The culture wells were rinse twice with
PBS for 3 minutes. Half a millilitre of PBS was added to
the well and the cells were scraped off with a tissue scraper
and transferred to a 1.5 ml Eppendorf tube. The wells were
rinsed with 0.5 ml PBS, which was transferred to the
Eppendorf tube as well. The sample was centrifuged at
5000 × g for 8 seconds. Maximum PBS was aspirated and
the cell pellet was resuspended in 0.1 ml lysis buffer (500
ml lysis buffer: 250 mg sodium deoxycholate, 5 mg phe-
nylmethyl sulfonyl fluoride (PMSF), 5 mg aprotinin, 500
ml nonidet P-40, 500 ml 10% (wt/vol) SDS) by pipetting
the cells up and down several times. The tubes were left on
ice for 5 minutes and vortexed for 30 seconds. The tubes
were microcentrifuged at maximum speed for 10 minutes
at 6°C. Fifty microliters of the supernatant was added in
duplicate from each osteo-induced and control sample to
wells in a 96-well plate. The kit, p-Nitrophenyl Phosphate
Liquid Substrate System (Sigma-Aldrich), was used and
50 μl of p-nitrophenyl phosphate (pNPP) was added to
each well. The absorbance was read at 405 nm on a micro-
plate reader as soon as possible after adding the pNPP
(time 0) and subsequent every 5 minutes for 20 minutes.
The absorbance was read against 100 μl of undiluted
pNPP. Covering it with aluminium foil screened the
microplate from light between readings.
Culture well total protein concentration
Both calcium deposition and alkaline phosphatase activ-
ity was evaluated against the total protein content of the
culture wells. Total protein concentration was determined
using a DC Bio-Rad protein method. In detail, 5 μl dupli-
cate samples of the cell lysate supernatant were added to
wells of a 96-well plate. Twenty-five microlitres of work-
ing reagent A (20 μl of reagent S per 1 ml of reagent A) and
200 μl of reagent B were added to each sample. A standard
curve was generated from bovine serum albumin samples
containing 4, 2, 0.5 and 0.25 mg/ml, respectively. The
microplate was read at an absorbance of 630 nm after 15
minutes.
Alizarin Red S staining
Alizarin Red S (Sigma-Aldrich), staining calcium deposits
orange red, was done by carefully aspirating the medium
from each well so as not to aspirate the cells. The cells
were fixed incubating in ice-cold 70% ethanol for 5 min-
utes at room temperature, before carefully aspirating the
alcohol and rinsing twice (5 minutes each) with water.
The water was aspirated and 1 ml 2% Alizarin Red S solu-
tion was added. The plate was incubated at room temper-
ature for 3 minutes, before removing the Alizarin Red S
solution and washing the wells five times with 2 ml water.
The pH value of the Alizarin Red S solution was adjusted
to 4.1–4.3 with ammonium hydroxide prior to the proce-
dure.
Von Kossa staining
Von Kossa staining of calcium-phosphate deposits was
performed. The cells were washed 3 times with PBS before
fixation of the cells with 10% formalin for 1 hour at room
temperature. The cells were washed 5 times with distilled
water before adding 1 ml of 5% silver nitrate (Sigma-
Aldrich) and exposing to UV light for 45 minutes. The
wells were washed 5 times with distilled water. Sodium
thiophosphate (5%) (Sigma-Aldrich) was added for 2
minutes and the cells were washed 3 times in distilled
water. Nuclear fast red (Sigma-Aldrich) staining was done
for 1 minute and the cells washed 5 times with distilled
water. Calcium-phosphate deposits stained black, nuclei
red and other tissues pink.
Chondrogenic in vitro differentiation
Chondrogenic differentiation was performed using a
micromass culture system [39]. Briefly, undifferentiated
cells (2.5 × 105 cells) in a 15 ml polypropylene tube were
centrifuged at 150 g for 5 min at room temperature to
form a pellet. Without disturbing the pellet, the cells were
cultured for 2 and 4 weeks in 0.5 ml complete chondro-
genic differentiation medium (Cambrex Bio Science) con-
taining 10 ng/ml TGF-β3. Media was completely
exchanged every 3 days. Pellets were fixed in 10% forma-
lin, imbedded in paraffin blocks and sectioned into 5 um
sections. Hematoxylin and Eosin stain (Sigma-Aldrich) as
well as Safranin O (Sigma-Aldrich) staining of gly-
cosaminoglycans confirmed chondrogenic differentiation
histologically. Hematoxylin and Eosin staining of slidesPage 7 of 9
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ing, sections were stained with 0.1% aqueous Safranin O
for 5 min and the nuclei was counterstained with
Weigert's iron hematoxylin (Sigma-Aldrich) according to
the protocol from Cambrex Bio Science [38].
Adipogenic in vitro differentiation
Adipogenesis was induced using the protocol described by
Pittenger et al. (1999) [40] and a slightly modified proto-
col of the one reported by Janderová et al. (2003) [35].
Six-well culture plates were seeded at 2.1 × 104 undifferen-
tiated MSCs per cm2 of tissue culture surface area in 0.3 ml
of media per tissue culture surface. The cells were
expanded until 100% confluency in regular expansion
media. The expansion media was completely changed
every 3 days.
At confluency some wells were stained to evaluated the
baseline formation of neutral lipid-vacuoles stainable
with Oil Red O (Sigma-Aldrich). The used Oil Red O
staining protocol was as follows; aspirate all the media off
the cells, wash once with 2 ml of PBS, replace the PBS with
2 ml of 10% formalin for 30 min at room temperature to
fixate the cells, replace the formalin with 2 ml of sterile
water for a few minutes, replace water with 60% isopropa-
nol for 5 minutes, replace isopropanol with 2 ml of Oil
Red O working solution made up as described by Cam-
brex, after 5 minutes the Oil red O solution was washed of
indirectly with tap water. Two ml of Harris hematoxylin
(Sigma-Aldrich) was added to the well for 1 minute before
being aspirated and the wells washed with warm tap
water. The wells were viewed using an inverted phase con-
trast microscope. Lipids appeared red and nuclei appeared
blue.
The remaining plates were after the cells reached 100%
confluency exposed to regular expansion media (negative
control), adipogenic induction media alone, (1 μM dex-
amethasone, 0.5 mM 3-isobutyl-1-methyl-xanthine
(IBMX), 10 μg/ml recombinant human (rh) insulin, 0.2
mM indomethacin, and 10% FCS in DMEM (Cambrex
Bio Science)) adipogenic maintenance media alone (10
μg/ml rh insulin and 10% FCS in DMEM (Cambrex Bio
Science)), cyclic exposure to adipogenic induction media
for 72 hour followed by 24 hours of maintenance media,
adipogenic induction media with 15% rabbit serum
(Sigma-Aldrich) alone, or cyclic exposure to 72 hours of
adipogenic induction media with 15% rabbit serum fol-
lowed by 24 hours of maintenance media. The media was
completely replaced every 3 days in wells not undergoing
a cyclic protocol. Adipogenic potential was assessed by
Oil Red O staining as described previously after 21 days of
exposure to induction medias.
Statistical analysis
Determination of any significant statistical difference
between control and induced samples in calcium deposi-
tion and alkaline phosphatase activity was performed
using SAS 9.0 software. The statistical method was
ANOVA (analysis of variance) for a completely rand-
omized design with sub-sampling. There were two treat-
ment levels (control versus induced), three replications
per level (3 culture wells per treatment) and two sub-sam-
ples per replication (duplicate measurements of absorb-
ance values). The response was the absorption readings
for alkaline phosphatase, calcium and protein measures.
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